PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50119C00007 — EXERCISE CLIN0003, UPDATE B.3. AND G.6.

EXERCISE CLIN0003, UPDATE B.3. AND G.6. is a federal NONE award for Department of Health and Human Services (HHS) held by VENATORX PHARMACEUTICALS, INC.. Estimated value $131.8M ($44.9M obligated). Current period of performance ends Sep 30, 2025. Last award drew 1 bidder. Place of performance: DOWNINGTOWN, PA. Related solicitation BAA18100SOL00003.

$131.8M
Estimated Value
$44.9M
Obligated
Sep 30, 2025
PoP End / Expires
1
Bidders (last award)
More in SCOUT — score this to your firm →See related expiring contracts →

Analysis

Public

VENATORX PHARMACEUTICALS, INC. holds $44.4M across 6 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Sep 30, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Contract facts

NONE
Contract number75A50119C00007
AgencyDepartment of Health and Human Services (HHS)
IncumbentVENATORX PHARMACEUTICALS, INC.
UEIMBBKNBU5DCC6
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13
Place of performanceDOWNINGTOWN, PA
Related solicitationBAA18100SOL00003
PoP end (current)Sep 30, 2025
Obligated$44.9M

Recompete timing

Public
Past PoP end (314 days ago)

Current PoP ended Sep 30, 2025 (314 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Track recompete timing in SCOUT →

Incumbent footprint

Public record

VENATORX PHARMACEUTICALS, INC.$44.4M obligated across 6 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$44.8M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Score this to your firm — $90 Pilot →

Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. 90 days · $90 · no annual contract · cancel anytime

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open VENATORX PHARMACEUTICALS, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50119C00007?

75A50119C00007 (EXERCISE CLIN0003, UPDATE B.3. AND G.6.) is a Department of Health and Human Services (HHS) award with an estimated value of $131.8M, currently held by VENATORX PHARMACEUTICALS, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50119C00007?

VENATORX PHARMACEUTICALS, INC. is the incumbent with $44.4M across 6 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2025.

When does 75A50119C00007 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50119C00007